Pharming Group N.V. (PHAR) Operating cash flow 2019–2025
Pharming Group N.V. (PHAR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$54.7MFY2025 · since FY2019: $74.1M → $54.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.7M | +3147.8% |
| FY2024 | -$1.8M | +89.6% |
| FY2023 | -$17.3M | -177.0% |
| FY2022 | $22.5M | -40.7% |
| FY2021 | $37.8M | -54.7% |
| FY2020 | $83.6M | +12.8% |
| FY2019 | $74.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAR financial trends
PHAR RevenuePHAR Net incomePHAR Net marginPHAR Gross profitPHAR Gross marginPHAR Operating incomePHAR Operating marginPHAR Free cash flowPHAR Capital expendituresPHAR Return on equityPHAR Stock buybacksPHAR Dividends paidPHAR Total assetsPHAR Total liabilitiesPHAR Shareholders’ equityPHAR overview →